Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Funk

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Oncogene|November 16, 1995
Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinaseT Herzinger, J O Funk, K Hillmer, et al.
Genes & Development|August 15, 1997
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoproteinJ O Funk, S Waga, J B Harry, et al.
Scandinavian Journal of Immunology|October 1, 1996
Protein kinase C activation is involved in ultraviolet B irradiation-induced endothelial cell ICAM-1 up-regulation and lymphocyte-endothelium interaction in vitroJ O Funk, E Holler, F Kohlhuber, et al.
Journal of Cutaneous Pathology|August 7, 1998
p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanomaJ O Funk, P I Schiller, M T Barrett, et al.
The Journal of Biological Chemistry|September 28, 2001
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of BaxT Samuel, H O Weber, P Rauch, et al.
The Journal of Biological Chemistry|March 30, 2001
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elementsT Albert, J Wells, J O Funk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1J O Funk, H Walczak, C Voigtländer, et al.
Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.
The Journal of Investigative Dermatology|July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activityM Böhm, U Schulte, J O Funk, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncogene|November 16, 1995
Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinaseT Herzinger, J O Funk, K Hillmer, et al.
Genes & Development|August 15, 1997
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoproteinJ O Funk, S Waga, J B Harry, et al.
Scandinavian Journal of Immunology|October 1, 1996
Protein kinase C activation is involved in ultraviolet B irradiation-induced endothelial cell ICAM-1 up-regulation and lymphocyte-endothelium interaction in vitroJ O Funk, E Holler, F Kohlhuber, et al.
Journal of Cutaneous Pathology|August 7, 1998
p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanomaJ O Funk, P I Schiller, M T Barrett, et al.
The Journal of Biological Chemistry|September 28, 2001
The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of BaxT Samuel, H O Weber, P Rauch, et al.
The Journal of Biological Chemistry|March 30, 2001
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elementsT Albert, J Wells, J O Funk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1J O Funk, H Walczak, C Voigtländer, et al.
Cancer|October 24, 2000
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphomaL M Heinzerling, M Urbanek, J O Funk, et al.
The Journal of Investigative Dermatology|July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activityM Böhm, U Schulte, J O Funk, et al.
Pageof 3